poisar

Stocks · News reference

Mangoceuticals’ Merger Partner, Nuclea Energy, Enters Into Definitive Agreement With Moltex Energy To Acquire Advanced Nuclear Technology Assets; Terms Undisclosed

BenzingaBenzinga Newsdesk

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.Asset-led transaction

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — MANGOCEUTICALS, INC. (MGRX)

    Filed: 2026-08-21 AccNo: 0001493152-26-039724 Size: 248 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits